Dr. Reddy's makes investment of Rs 565.40 crore in DRL Russia
The fund infused by the company into DRL Russia will be used for working capital requirements
Dr. Reddy's Laboratories has made an investment of Rs 565.40 crore in Dr. Reddy’s Laboratories LLC, Russia (DRL Russia), a step-down wholly-owned subsidiary, for a total equity stake of 45.19%.
DRL Russia is a Pharmaceutical company registered in Russian Federation distributing pharmaceutical medicines in the country. The fund infused by the company into DRL Russia will be used for working capital requirements.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
